I synthesized some novel heterocycles which shows a particular in-vitro bioactivity. After this, I decided to go for its docking study. Synthesized heterocycles are in the racemic mixture; also the in-vitro bioactivity is assessed by using a racemic mixture. My question is, for docking purpose is it necessary to use each and every individual from the racemic mixture one by one or the individual single isomer structure (among its racemic mixture) after energy minimization is sufficient? Out of this which method is correct?

(For energy minimization I used ChemDraw program)

More Sameer Karpe's questions See All
Similar questions and discussions